- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 451/02 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamineCyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropaneCyclic acetals thereof
Patent holdings for IPC class C07D 451/02
Total number of patents in this class: 479
10-year publication summary
|
39
|
38
|
42
|
32
|
22
|
41
|
29
|
19
|
17
|
26
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 358 |
17 |
| Boehringer Ingelheim International GmbH | 4485 |
15 |
| Merck Sharp & Dohme LLC | 3734 |
12 |
| Novartis AG | 10160 |
11 |
| Bristol-myers Squibb Company | 4751 |
11 |
| Merck Patent GmbH | 5761 |
11 |
| Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 110 |
9 |
| Yangtze River Pharmaceutical (Group) Co., Ltd. | 147 |
9 |
| Skyhawk Therapeutics, Inc. | 151 |
9 |
| Orsobio, Inc. | 19 |
8 |
| Nxera Pharma UK Limited | 185 |
7 |
| Syngenta Participations AG | 1473 |
6 |
| Orion Corporation | 798 |
6 |
| Theravance, Inc. | 61 |
6 |
| Eisai R&D Management Co., Ltd. | 1161 |
6 |
| F. Hoffmann-La Roche AG | 7784 |
5 |
| The Regents of the University of California | 20987 |
5 |
| Janssen Pharmaceutica N.V. | 3129 |
5 |
| Assistance Publique-hopitaux de Paris (aphp) | 572 |
5 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3337 |
5 |
| Other owners | 311 |